Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
about
BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic LeukemiaThe role of Eph receptors in lens function and diseaseThe Polymorphisms with Cataract Susceptibility Impair the EPHA2 Receptor Stability and Its Cytoprotective FunctionMutations in the EPHA2 gene are a major contributor to inherited cataracts in South-Eastern Australia.Association between polymorphisms of OGG1, EPHA2 and age-related cataract risk: a meta-analysis.EPHA2 MUTATIONS CONTRIBUTE TO CONGENITAL CATARACT THROUGH DIVERSE MECHANISMSDlg-1 Interacts With and Regulates the Activities of Fibroblast Growth Factor Receptors and EphA2 in the Mouse Lens.Breakdown of interlocking domains may contribute to formation of membranous globules and lens opacity in ephrin-A5(-/-) mice.EphA2 and Src regulate equatorial cell morphogenesis during lens development.EphA2 is a functional receptor for the growth factor progranulin.Roles of EphA2 in Development and Disease.EphA2 and ephrin-A5 are not a receptor-ligand pair in the ocular lens.Germ-line and somatic EPHA2 coding variants in lens aging and cataract.A recurrent splice-site mutation in EPHA2 causing congenital posterior nuclear cataract.The SAM domain inhibits EphA2 interactions in the plasma membrane.Molecular Genetics of Cataract.Screening, genetics, risk factors, and treatment of neonatal cataracts.
P2860
Q26765624-A52CE9D2-5C8F-439B-85C7-875CF7416726Q27007359-344F2C1E-AB52-4189-A65F-1632EDD0C1B8Q28395504-5EE24DB7-6AA0-4A90-8371-1EEDBF23B8E6Q34981110-1D022A54-0FB1-4700-BB76-1CCB98ED0DCFQ36147070-D14E0441-75F4-4B02-9DA5-35D9F0533CCBQ36524385-08EAC353-4D86-41DA-914A-A67C0A91B24CQ36630953-C8234C30-87D7-4F44-9853-E6C4F7FFFF3CQ36828540-E6300B46-B0E1-4491-9156-4B114D186104Q37209165-906A7D95-B3E3-4E3B-AEFB-B372E36EF035Q37488302-842DA39B-A701-4B47-AC0A-768BD45A99C6Q37584993-252C3E3A-BF7A-41EE-841F-8CF3F20D724DQ46756335-4E212A49-3010-44B9-96AD-4D50CB973A50Q47267611-AFB7176B-765B-4A64-94F4-73ED661641D0Q48176345-5791B6D4-F773-49CF-9AE9-DC2DA5B1EDE9Q51123807-40B39068-625F-41F7-80F1-D84915FEF8E2Q53563867-96DA842D-CFF7-46BB-9A83-E141A870735EQ54361246-4D4F1129-5423-48F1-A7A0-285B1D7F1645
P2860
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@ast
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@en
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@nl
type
label
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@ast
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@en
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@nl
prefLabel
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@ast
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@en
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@nl
P2093
P2860
P1433
P1476
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
@en
P2093
Alexander I Son
Jeong Eun Park
Lianqing Wang
Renping Zhou
P2860
P304
P356
10.1371/JOURNAL.PONE.0036564
P407
P577
2012-05-03T00:00:00Z